What is the standard treatment protocol for a patient diagnosed with central serous retinopathy, confirmed by optical coherence tomography (OCT)?

In cases of central serous retinopathy (CSR), the standard treatment protocol typically emphasizes a conservative approach, particularly in situations where symptoms are mild and vision is not significantly affected. Monitoring the patient monthly for resolution is often sufficient, as CSR can resolve spontaneously over time without medical intervention. This observation allows the clinician to track changes in the retina and assess the patient's visual acuity.

Optical coherence tomography (OCT) plays a crucial role in diagnosing CSR by providing high-resolution imaging of the retina, which helps confirm the condition and monitor the status of any subretinal fluid accumulation. The natural history of CSR suggests that many cases improve within a few months, making active treatment unnecessary unless the condition is persistent or vision loss becomes significant.

Interventions like cryotherapy, laser treatment, or intravitreal steroid injections are typically reserved for chronic cases or when there is a threat to vision. In most instances, these aggressive treatment options may not be warranted for patients with newly diagnosed CSR who have mild symptoms and are likely to experience resolution. Therefore, the choice to monitor the condition monthly aligns with established best practices for managing CSR.